N-acetylcysteine attenuates the cuprizone-induced behavioral changes and oligodendrocyte loss in male C57BL/7 mice via its anti-inflammation actions

Quetiapine mitigates the neuroinflammation and oligodendrocyte loss in the brain of C57BL/6 mouse following cuprizone exposure for one week

(2015) Yuan Shao et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The cuprizone-induced changes in 1H-MRS metabolites and oxidative parameters in C57BL/6 mouse brain: Effects of quetiapine

(2015) Yinghua Xuan et al.   NEUROCHEMISTRY INTERNATIONAL

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review

(2015) Deepmala et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Clinical management of negative symptoms of schizophrenia: An update

(2015) Evangelia M. Tsapakis et al.   PHARMACOLOGY & THERAPEUTICS

N-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's disease

(2015) D J Wright et al.   Translational Psychiatry

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

(2014) Olivia Dean et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Concurrent changes in 1H MRS metabolites and antioxidant enzymes in the brain of C57BL/6 mouse short-termly exposed to cuprizone: Possible implications for schizophrenia

(2014) Yinghua Xuan et al.   NEUROCHEMISTRY INTERNATIONAL

Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis

(2014) Jelle Praet et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis

(2014) Anna Gądek-Michalska et al.   Pharmacological Reports

Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone

(2013) Haiyun Xu et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats

(2013) Marisa Möller et al.   METABOLIC BRAIN DISEASE

Cuprizone short-term exposure: Astrocytic IL-6 activation and behavioral changes relevant to psychosis

(2013) Tomoaki Tezuka et al.   NEUROBIOLOGY OF DISEASE

N-acetyl-L-cysteine protects against cadmium-induced neuronal apoptosis by inhibiting ROS-dependent activation of Akt/mTOR pathway in mouse brain

(2013) Sujuan Chen et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update

(2013) I. E. Sommer et al.   SCHIZOPHRENIA BULLETIN

Update on Typical and Atypical Antipsychotic Drugs

(2012) Herbert Y. Meltzer   Annual Review of Medicine

N-Acetylcysteine for the Treatment of Glutathione Deficiency and Oxidative Stress in Schizophrenia

(2012) Dikoma C. Shungu   BIOLOGICAL PSYCHIATRY

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine

(2012) Marisa Möller et al.   BRAIN BEHAVIOR AND IMMUNITY

L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the ‘collusion’ hypothesis for increased extracellular L-glutamate concentration in neuroinflammation

(2012) Junpei Takaki et al.   Journal of Neuroinflammation

N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: Behavioral and biochemical analyses in rats

(2012) Irena Smaga et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination

(2012) Yanbo Zhang et al.   SCHIZOPHRENIA RESEARCH

Diffusion Tensor Imaging Findings of White Matter Changes in First Episode Schizophrenia: A Systematic Review

(2012) Carissa Nadia Kuswanto et al.   Clinical Psychopharmacology and Neuroscience

Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice

(2011) P. Chandran et al.   NEUROSCIENCE

Recovery of Behavioral Changes and Compromised White Matter in C57BL/6 Mice Exposed to Cuprizone: Effects of Antipsychotic Drugs

(2011) Haiyun Xu et al.   Frontiers in Behavioral Neuroscience

Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats

(2010) Kwok Ho Christopher Choy et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

White matter volume abnormalities and associations with symptomatology in schizophrenia

(2010) Nikolaos Makris et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics

(2010) Haiyun Xu   Frontiers in Behavioral Neuroscience

Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone.

(2009) Haiyun Xu et al.   BEHAVIORAL NEUROSCIENCE

Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia

(2009) Hong-Ju Yang et al.   BRAIN RESEARCH

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway

(2009) O. D. Howes et al.   SCHIZOPHRENIA BULLETIN

Theory of mind impairment in schizophrenia: Meta-analysis

(2009) Emre Bora et al.   SCHIZOPHRENIA RESEARCH

Beneficial effects ofN-acetylcysteine in treatment resistant schizophrenia

(2009) Mahmut Bulut et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

(2008) Seetal Dodd et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Demonstration of an anti-oxidative stress mechanism of quetiapine

(2008) Haiyun Xu et al.   FEBS Journal